Life science News and Research

RSS

Inspire Medical Systems completes $40 million Series E financing

Inspire Medical Systems, Inc. announced today that it has completed a Series E financing of $40 million. The financing round was strategically timed to coincide with the commercial launch of the Inspire Upper Airway Stimulation (UAS) therapy in the United States.

15 May 2014

Flatiron Health agrees to acquire Altos Solutions

Altos Solutions, creators of OncoEMR, the first web-based oncology-specific electronic medical record, today announced an agreement to be acquired by Flatiron Health.

9 May 2014

NanoString receives license from Health Canada to market Prosigna Breast Cancer Prognostic Gene Signature Assay

NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that it has received a Class III Medical Device License from Health Canada, clearing the company to market its Prosigna Breast Cancer Prognostic Gene Signature Assay for assessing a woman's 10-year risk of distant recurrence and accurately identifying the intrinsic biologic subtype of the tumor.

From NanoString Technologies 7 May 2014

Trends, opportunities and threats in the life science industry: an interview with Bob Coughlin, CEO, MassBio

We were extremely excited to launch the Impact 2020 report at our annual meeting. Our five-year strategic plan is focused on value, early-stage financing and ensuring more patient-centered discussions.

5 May 2014

Frozen meals closer to meeting Dietary Guidelines than quick service restaurant meals

New analysis of data from the 2003-2010 What We Eat In America (WWEIA) National Health and Nutrition Examination Survey (NHANES), a program of the Centers for Disease Control and Prevention (CDC), indicates that consumers of frozen meals (1) compared to consumers of quick service restaurant (QSR) meals (2) had lower calorie intakes and better Healthy Eating Index (HEI) score. In fact, the analysis revealed that those who consumed frozen meals consumed 253 fewer calories than those who consumed a quick service restaurant meal.

1 May 2014

People who take statin drugs develop heart disease and obesity-related illnesses

People who take statin drugs to lower their cholesterol appear to have developed a false sense of security that could lead to heart disease and other obesity-related illnesses.

29 Apr 2014

Voluntis closes €20.75 million ($29 million) Series D financing round

Voluntis, a company pioneering therapeutic companion software, today announced the completion of its Series D financing round. With a total of €20.75 million ($29 million), this fund raising is one of the largest rounds of investment in the m-health sector this year.

28 Apr 2014

GEN Publishing introduces semi-monthly digital publication focusing on OMICs technologies

GEN Publishing recently introduced Clinical OMICs a semi-monthly digital publication focusing on the application of OMICs technologies in clinical settings. These advanced techniques, such as next-gen sequencing, are beginning to transform medical care just as they revolutionized basic life science research over the past decade-and-a-half.

26 Apr 2014

Wilson Therapeutics closes $40 million Series B financing

Wilson Therapeutics, a biopharmaceutical company, today announced that it has closed a $40 million Series B financing co-led by new investors, Abingworth LLP and MVM Life Science Partners LLP. The company's founding investor, HealthCap, also participated in the round.

16 Apr 2014

TSRI announces formation of Scripps Advance

The Scripps Research Institute (TSRI) today announced the formation of Scripps Advance, a new drug discovery initiative to translate early-stage biomedical research projects, both internal and external to TSRI, into clinical development candidates.

15 Apr 2014

Researcher at Fox Chase Cancer Center wins a new Cytation™ 3 Cell Imaging Multi-Mode Reader in BioTek's "Think Possible" Application Contest

BioTek congratulates Dr. Jeff Peterson of the Fox Chase Cancer Center in Pennsylvania for winning a new Cytation™ 3 Cell Imaging Multi-Mode Reader in BioTek's "Think Possible" Application Contest. Entrants were judged on a short essay that they submitted, detailing the application that they think is possible for their specific research using the Cytation 3. As an Associate Professor, Dr. Peterson studies chemical biology and kinase signaling in cancer.

14 Apr 2014

Experts and entrepreneurs to gather at 2014 Biotech China on 14-16 May

With just one month until 2014 Biotech China, experts, entrepreneurs and decision-makers from the international biotechnology industry will gather at the heart of the Chinese biotechnology industry on May 14-16th, 09:00 AM-06:00 PM in Nanjing China.

10 Apr 2014

Gerresheimer’s revenues increase EUR 297.5M to 0.3% in first quarter 2014

Gerresheimer AG, one of the leading partners to the pharma and healthcare industry worldwide, began financial year 2014 with a solid start."I am satisfied with our performance in the first quarter of 2014.

10 Apr 2014

Covaris' European subsidiary to commence operations on May 1, 2014

Covaris, Inc., an innovator in the life science tools and the clinical diagnostic market spaces, announced today that its European subsidiary, Covaris Ltd, which is located in the United Kingdom, will commence operations on May 1, 2014.

10 Apr 2014

Think Possible video from BioTek wins Silver Telly Award

BioTek's Think Possible video, created by Hen House Media, was recently awarded a Silver Telly Award in the "Non-Broadcast, Motivational" category as part of the 35th Annual Telly Awards. Standing out from over 12,000 entries, the Silver Telly is the highest honor bestowed upon film and video productions, and awarded to less than 10 percent of entries.

9 Apr 2014

Scientists uncover surprising link between brain development and gene tied to breast cancer

Scientists at the Salk Institute have uncovered details into a surprising-and crucial-link between brain development and a gene whose mutation is tied to breast and ovarian cancer.

9 Apr 2014

Nanostring Technologies launches nCounter PanCancer Pathways Panel

NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced the launch of the nCounter® PanCancer Pathways Panel, a highly-multiplexed, digital gene expression assay that offers a unique way for translational researchers to investigate cancer biology across all major cancer pathways.

From NanoString Technologies 8 Apr 2014

BioTek’s MultiFlo™ FX now available with Random Access Dispense technology

BioTek’s MultiFlo™ FX is now available with optional RAD™ (Random Access Dispense) technology to further extend its application range and flexibility. RAD technology offers single-channel dispensing to random individual microplate wells along with rapid reagent dispensing into large volume wells of 6- to 24- well microplates. MultiFlo FX can also be separately configured with an optional wash module for 6- to 384-well plates.

4 Apr 2014

Bjond raises $3.25M in Series A financing to accelerate its flagship software

Today Bjond, Inc. announced that it closed $3.25 million in Series A financing. Draper Triangle Ventures led the round, joined by co-investors TriStar Technology Ventures and Hopen Life Science Ventures.

4 Apr 2014

Seward increases production capacity for Stomacher blender bags in the UK

Seward Ltd., manufacturer of the world leading range of original Stomacher paddle blenders and accessories used in sample preparation for microbiological analysis, has increased production capacity for Stomacher blender bags with additional manufacturing in the UK.

4 Apr 2014

Life science News and Research

Inspire Medical Systems completes $40 million Series E financing

Flatiron Health agrees to acquire Altos Solutions

NanoString receives license from Health Canada to market Prosigna Breast Cancer Prognostic Gene Signature Assay

Trends, opportunities and threats in the life science industry: an interview with Bob Coughlin, CEO, MassBio

Frozen meals closer to meeting Dietary Guidelines than quick service restaurant meals

People who take statin drugs develop heart disease and obesity-related illnesses

Voluntis closes €20.75 million ($29 million) Series D financing round

GEN Publishing introduces semi-monthly digital publication focusing on OMICs technologies

Wilson Therapeutics closes $40 million Series B financing

TSRI announces formation of Scripps Advance

Researcher at Fox Chase Cancer Center wins a new Cytation™ 3 Cell Imaging Multi-Mode Reader in BioTek's "Think Possible" Application Contest

Experts and entrepreneurs to gather at 2014 Biotech China on 14-16 May

Gerresheimer’s revenues increase EUR 297.5M to 0.3% in first quarter 2014

Covaris' European subsidiary to commence operations on May 1, 2014

Think Possible video from BioTek wins Silver Telly Award

Scientists uncover surprising link between brain development and gene tied to breast cancer

Nanostring Technologies launches nCounter PanCancer Pathways Panel

BioTek’s MultiFlo™ FX now available with Random Access Dispense technology

Bjond raises $3.25M in Series A financing to accelerate its flagship software

Seward increases production capacity for Stomacher blender bags in the UK

Ultimate guide to the essential tools for the characterization of proteins, polymers and nanoparticles eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News